Moderately
Showing 1 - 25 of 5,290
Cervical Tumor, Adaptive Radiotherapy, Radiotherapy; Adverse Effect Trial in Beijing (Moderately hypofractionated adaptive
Recruiting
- Cervical Neoplasm
- +2 more
- Moderately hypofractionated adaptive radiotherapy (ART)+ High-dose rate (HDR) Brachytherapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 15, 2023
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Transfemoral Amputation Trial in Wiesbaden (Amputation-specialized rehabilitation, Non-amputation-specialized rehabilitation)
Recruiting
- Transfemoral Amputation
- Amputation-specialized rehabilitation
- Non-amputation-specialized rehabilitation
-
Wiesbaden, GermanyMEDIAN Clinics
Sep 13, 2023
Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)
Recruiting
- Chemotherapy Induced Nausea and Vomiting
-
Mount Olive, AlabamaRudolph M Navari
Oct 8, 2023
Ulcerative Colitis Trial (Tilpisertib Fosmecarbil, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Tilpisertib Fosmecarbil
- Placebo
- (no location specified)
Sep 1, 2023
Community-Acquired Pneumonia Trial in Garches (Stop antibiotic, Continue the antimicrobial treatment)
Not yet recruiting
- Community-Acquired Pneumonia
- Stop antibiotic
- Continue the antimicrobial treatment
-
Garches, FranceInfectious diseases department, Raymond-Poincaré Hospital - APHP
Jun 6, 2023
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Depressive Symptoms Trial in Nancy (Nordic Walking)
Completed
- Depressive Symptoms
- Nordic Walking
-
Nancy, Franceassociation JBPMM
Jan 26, 2023
Ulcerative Colitis, Ulcerative Colitis Chronic Trial (Mirikizumab)
Not yet recruiting
- Ulcerative Colitis
- Ulcerative Colitis Chronic
- (no location specified)
Mar 6, 2023
Ulcerative Colitis Trial (Mirikizumab IV, Mirikizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Mirikizumab IV
- Mirikizumab SC
- (no location specified)
Mar 24, 2023
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Moderately hypofractionated conformal radiation combined With S-1)
Completed
- Esophageal Squamous Cell Carcinoma
- Moderately hypofractionated conformal radiation combined With S-1
-
Guangzhou, Guangdong, ChinaHui Liu
Oct 25, 2022
Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)
Not yet recruiting
- Ulcerative Colitis
- IV MK-7240
- +3 more
- (no location specified)
Sep 27, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- (no location specified)
Aug 16, 2023
Coronary Artery Disease Trial (LithiX Coronary Hertzian Contact Lithotripsy Catheter (LithiX Coronary HCLC; LithiX))
Not yet recruiting
- Coronary Artery Disease
- LithiX Coronary Hertzian Contact Lithotripsy Catheter (LithiX Coronary HCLC; LithiX)
- (no location specified)
Apr 13, 2023
Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)
Not yet recruiting
- Ulcerative Colitis
- APL-1401
- Placebo
-
Whittier, CaliforniaNew Hope Research Development
Feb 15, 2023
Ulcerative Colitis Trial (Efavaleukin alfa, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Efavaleukin alfa
- Placebo
- (no location specified)
Jan 3, 2023
In Vivo Biofilm Accumulation on Implants With 3 Different
Not yet recruiting
- Peri-Implantitis
- moderately rough surface
- implantoplasty
- (no location specified)
Sep 20, 2023
Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)
Not yet recruiting
- Prostate Cancer
- Radiotherapy standard
- Radiotherapy Hypo-FLAME
- (no location specified)
Jan 30, 2023
Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)
Active, not recruiting
- Crohn's Disease
- CT-P13 SC (Infliximab)
- Placebo SC
-
Warszawa, PolandWIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022